Dividends CalendarEarnings Calendar
NBIX

NBIX | Neurocrine Biosciences Inc

Neurocrine Biosciences Inc
Category: Consumer goods
  • Industry: Drug Manufacturers - Major

Quick infos

  • Headquarters:   San Diego, California, United States

Trade prices

  • Volume:
  • Market Cap: 8.98B
  • Prev closed:
  • Open:
  • High:
  • Low:
  • 52 week low:
  • 52 week high:
  • Dividends:No Dividends

Next ER: November 9, 2020  After Market Closes



Top Stories (NBIX)

    About the Company

    Neurocrine Biosciences is a publicly traded biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    February 2, 2021
    November 9, 20200.97 / -0.03258.5M / 283.68M
    August 3, 20200.81 / 0.61302.4M / 261.31MBeat!
    May 6, 20200.39 / 0.54237.1M / 226.53MBeat!
    February 4, 20200.35 / 0.78244.1M / 231.54MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Nov 23, 2020 94.22 89.93
    94.22
    89.92
    868.22K 5.87%
    Nov 20, 2020 89.00 87.70
    90.22
    87.56
    1.17M 1.77%
    Nov 19, 2020 87.45 87.28
    88.01
    86.02
    2.14M 0.62%
    Nov 18, 2020 86.91 91.49
    91.86
    86.80
    795.64K -5.28%
    Nov 17, 2020 91.75 92.70
    93.50
    90.99
    760.65K -1.3%
    Nov 16, 2020 92.96 92.92
    95.15
    92.03
    852.98K 1.07%
    Nov 13, 2020 91.98 90.74
    94.81
    90.29
    708.21K 1.69%
    Nov 12, 2020 90.45 90.30
    92.90
    88.57
    889.52K 1.30%
    Nov 11, 2020 89.29 89.03
    91.80
    88.21
    1.46M 1.95%
    Nov 10, 2020 87.58 91.03
    95.99
    86.66
    3.62M -14.81%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:1992
    • Employees:700

    News

    News for (NBIX)

    This company doesn't provide a dividend.


    Talk about Neurocrine Biosciences Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 9, 2020 (Same day)

    mcd hain spg icpt btu iii unit mwa zyne cara tlry acb 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 72
    HOLD 28
    SELL 0

    Their Official Profiles 

    WikipediaLinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Swing Trading For Dummies
    Buy on Amazon

    Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.

    Take advantage of price swings in strongly trending securities and pump up your portfolio!